We leverage digital pathology AI for the future of precision medicine
Fast, reliable, and robust AI solutions for clinical development, translational research, and companion diagnostics in immuno-oncology, and beyond
Clinical Development
Translational Research
Clinical Development
We provide custom digital pathology AI tools for accurate and precise biomarker quantification for patient stratification and endpoint analysis. Our AI provides reliable data, increasing the probability of clinical trial success.
We deploy AI algorithms at biopharmaceutical companies, CROs or trial sites to support clinical trial development
For prospective clinical trials, our AI correlates the biomarker status to the patient outcome
Our AI allows retrospective investigation of clinical trial data for patient outcome and pathology data/biomarkers
We develop AI-based companion diagnostics
Translational Research
We identify complex novel biomarkers based on digital pathology AI for future precision medicines, supporting personalized therapy for improved patient outcomes.
We build custom AI algorithms for the identification of biomarkers in immuno-oncology and other therapeutic areas
We utilize AI to identify biomarkers from complex multi-omics data
We work with a dedicated project team of leading pathologists and data scientists providing in-depth technical, scientific, and clinical expertise
In co-operation with partner laboratories, we develop efficient processes for sample collection, sample processing, digitization and data generation
Find out more about Mindpeak precision medicine
Company information
Local court Hamburg HRB 151143
Managing director:
Felix Faber
V.A.T. identification number:
DE318495606
Founded in 2018
.webp)
© 2024 Mindpeak GmbH
Supported by:
